“… without so called ‘evidence’ there is no seat at the guideline table. This is the fundamental ‘commissioning bias,’ the elephant in the room, because the drug industry controls and funds most research. So the drug industry and EBM [evidence…
Read more
The abstract of this article (written by David Cohen and David Jacobs, published in Debates in Neuroscience ) says: “This contribution to the ‘antidepressant debate’ focuses on the validity of randomized controlled trials (RCTs). We argue that: (a) made-up psychiatric diagnostic categories destroy the…
Read more
“Antidepressants are not antidepressants – an alternative approach to drug action and implications for the use of antidepressants” is an article written by Dr. Joanna Moncrieff (psychiatrist) and published in the BJPsych Bulletin (Jan. 30th 2018) as part of their “Against…
Read more
The full title of this paper – published Sept. 2017 in The Lancet Psychiatry – is “The effects of improving sleep on mental health (OASIS): a randomised controlled trial with mediation analysis”. “Background Sleep difficulties might be a contributory causal factor in the…
Read more
Prof. Katrina Skewes McFerran writes: “It’s an incredible feeling to connect in a meaningful way with angry young people who feel excluded, rejected and unhappy. My profession, music therapy, uses music to forge those connections, whether by drumming together as…
Read more
TED Talk (13 minute video) … The video’s producers say: “When a new drug gets tested, the results of the trials should be published for the rest of the medical world — except much of the time, negative or inconclusive…
Read more
Although several years old, this paper – “NICE Under Scrutiny” still has great relevance. It looks at the impact of the National Institute for Health and Clinical Excellence (NICE) guidelines on the provision of counselling/psychotherapy in the UK. Produced by…
Read more
In this book (published 2013), Dr. Ben Goldacre (psychiatrist) argues that: “Drugs are tested by the people who manufacture them, in poorly designed trials, on hopelessly small numbers of weird, unrepresentative patients, and analysed using techniques which are flawed by…
Read more